Dicerna Pharmaceuticals, Inc.
Methods and compositions for inhibiting expression of LDHA
Last updated:
Abstract:
This disclosure relates to oligonucleotides, compositions and methods useful for reducing LDHA expression, particularly in hepatocytes.
Status:
Grant
Type:
Utility
Filling date:
12 Oct 2018
Issue date:
29 Mar 2022